smoked and had no previous history of visual impairment. Conditioning included busulphan (16 mg/kg) and We report the case of a BMT recipient who developed cyclophosphamide (120 mg/kg). GVHD prophylaxis was blindness 2. months after BMT. Microvascular retinowith cyclosporine (3 mg/kg/day i.v. since day −1 and pathy, cortical blindness and other ocular pathologies 12 mg/kg/day p.o. when she was able to tolerate oral mediwere excluded with appropriate tests. Electrophysiologications, adjusted according to plasma levels), and prednical studies showed retinal damage without excluding an sone. She engrafted neutrophils and platelets on days 13 optic nerve lesion. The patient, who had several risk and 11, respectively. On day +21, she developed cutaneous factors for neurologic-induced cyclosporine toxicity, and intestinal acute grade IV GVHD that subsided with improved with cyclosporine withdrawal. Our findings high-dose steroids, antithymocyte immunoglobulin and stress the need of electrophysiological tests to exclude anti-IL-2 receptor monoclonal antibody. S. aureus bacterieneuroretinal damage in patients receiving cyclosporine mia and P. carinii pneumonia were diagnosed on days 39 after BMT.
1
diminished amplitude in both eyes ( Figure 1 ). Delay in However, early after BMT, cortical blindness and axonal conduction was also observed on peripheral nerve microvascular retinopathy are the two main causes of deterelectromyogram. iorating vision. 2, 3 Magnetic resonance scans and fundusco-CMV and HIV infection, arterial hypertension, thrompic examination, respectively, are the cornerstones for the boembolic disease, thrombotic microangiopathy and coagudiagnosis of these two clinical entities. The use of cyclospolation disorders were excluded with appropriate tests. Antirine and/or the conditioning regimen 2,4,5 have been implinuclear antibodies were negative. It was concluded that the cated in the pathogenesis of both. patient suffered from toxic retinal damage, without excludWe report the case of a BMT recipient who complained ing associated optic nerve toxicity. of deteriorating vision 2. months after BMT and in whom
The patient had been treated in the 3 previous weeks repeated funduscopic examinations and magnetic resonance with trimethoprim/sulfamethoxazole (to treat P. carinii scans failed to show any microvascular lesion/cerebral pneumonia), teicoplanin (for S. aureus septicemia), ganpathology. Electroretinogram (ERG) and visually evoked ciclovir (for acyclovir-resistant gastrointestinal herpes cortical potential (VECPs) were necessary to establish the simplex), cyclosporine and monoclonal antibodies against diagnosis of retinal damage, without excluding associated neural toxicity. Our findings stress the importance of these the IL-2 receptor (for GVHD). She also received functional tests to exclude ocular cyclosporine toxicity in supportive/prophylactic therapy with multivitamins, total BMT recipients.
parenteral nutrition, antiacids, ansiolitics and fluconazole. None of these drugs, except cyclosporine, have been previously implicated in the development of blindness. CycloCase report sporine levels were always within therapeutic ranges after BMT up to 1 week before development of blindness, when A 36-year-old woman underwent an HLA-identical related a cyclosporine level of 513 mg/dl was present. Cyclospor-BMT for CML in first chronic phase. She had never ine-related retinal toxicity was then suspected and the drug was stopped. No major changes were made with the other Discussion weeks) after BMT 3 and it is usually accompanied by other neurological symptoms. Magnetic resonance scan findings are typical. 7 The recovery of vision is almost immediate We report the case of a patient who suddenly developed blindness early after BMT. Microvascular retinopathy and after cyclosporine withdrawal. The slower recovery of vision and the normality of magnetic resonance also cyclosporine-induced cortical blindness were the two diagnoses to be excluded initially.
exclude this diagnosis.
In this patient, after other less frequent ocular pathologies Microvascular retinopathy is observed after BMT in up to 10% of allogeneic BMT recipients although it is symptoafter BMT had been excluded, the 'unrecordable' ERG and the increased delay and diminished amplitude in both eyes matic in only half. Most patients have been conditioned with TBI and cyclophosphamide. 2, 6 Multiple cotton-wool in VECPs suggested retinal plus/minus optic nerve toxic damage.
8 spots in the fundus, bilateral optic-disc edema, retinal hemorrhages and lipid deposits are the findings for funAlthough the patient had received multiple medications after BMT, cyclosporine is the drug most probably impliduscopic diagnosis. Withdrawal of cyclosporine is associated with resolution after several months. The lack of findcated in loss of visual acuity in this case since: (1) she improved when cyclosporine was withdrawn; (2) several ings on funduscopic examination excludes this diagnosis.
Cortical blindness is usually observed early (in the first circumstances that have been implicated as contributing In summary, in every patient who develops severe loss
